Interparfums header image

Interparfums

ITP

Equity

ISIN FR0004024222 / Valor 86977

Euronext - Euronext Paris (2025-10-17)
EUR 30.06+1.35%

Interparfums
UMushroom community rating:

star star star star star
0.00 0 votes No rating yet
NegativeNeutralPositive

About company

Interparfums, Inc. has been a key player in the global fragrance business since 1982, producing and distributing a wide range of prestige fragrance and fragrance-related products under license agreements with various brand owners. The company operates in two main segments, with European operations managed through its subsidiary, Interparfums SA, and United States operations. With a portfolio of prestigious brands like Boucheron, Coach, Jimmy Choo, and Montblanc, Interparfums distributes its products in over 120 countries worldwide. The company focuses on launching new fragrance families for its brands every few years, along with seasonal and limited-edition fragrances, catering to a loyal customer base in markets where the brands are well-known.

Summarized from source with an LLMView SourceSector: Healthcare

Latest Results (04.10.2025):

Interparfums reported record financial results for the fourth quarter of 2024, showcasing significant growth in net sales and earnings. The company achieved a diluted EPS of $5.12, surpassing expectations and reaffirmed its guidance for 2025. Additionally, Interparfums announced a 7% increase in its cash dividend, reflecting its strong financial performance and confidence in continued growth.

Record Net Sales

Interparfums reported net sales of $362 million for the fourth quarter of 2024, marking a 10% increase compared to the same period in 2023. This growth was broad-based across their portfolio, driven by strong demand for key brands globally.

Earnings Per Share Exceeds Expectations

The company achieved a diluted EPS of $5.12 in Q4 2024, up 8% from $4.75 in Q4 2023. Diluted EPS before impairment was $5.18, exceeding expectations and setting a new record for the company.

Reaffirmed 2025 Guidance

Interparfums reaffirmed its 2025 guidance, projecting net sales of $1.51 billion and EPS of $5.35, both representing a 4% increase. Despite economic uncertainties and foreign exchange impacts, the company remains confident in achieving its targets.

Increased Cash Dividend

The Board of Directors approved a 7% increase in the annual cash dividend rate to $3.20 per share, up from $3.00 per share, demonstrating continued confidence in the company's financial strength and growth prospects.

Summarized from source with an LLMView Source

Key figures

-26.5%1Y
-18.2%3Y
-0.10%5Y

Performance

30.1%1Y
30.9%3Y
31.9%5Y

Volatility

Market cap

2927 M

Market cap (USD)

Daily traded volume (Shares)

45,286

Daily traded volume (Shares)

1 day high/low

40.45 / 39.85

1 day high/low (USD)

52 weeks high/low

0.00 / 0.00

52 weeks high/low (USD)

Dividend ex-date

01 January, 2022

Dividend ex-date

Dividend

0.00

Dividend (USD)

Dividend yield (p.a.)

0.00%

Dividend yield (p.a.)

0.002022
0.002023
0.002024

Est dividend (USD)

0.00%2022
0.00%2023
0.00%2024

Est dividend yield

P/E ratio

10.00

P/E ratio

00.002022
00.002023
00.002024

Est P/E ratio

EPS

0.00

EPS (USD)

0.002022
0.002023
0.002024

Est EPS (USD)

Ratings & reviews

star star star star star

0.00

0 votes
Performance:
starstarstarstarstar
0.00
Innovation:
starstarstarstarstar
0.00
Society:
starstarstarstarstar
0.00
Nature:
starstarstarstarstar
0.00

EQUITIES OF THE SAME SECTOR

Masimo Corp
Masimo Corp Masimo Corp Valor: 493578
starstarstarstarstar

Annual Return

-50%0%+50%

Risk level

110
-0.30%USD 146.78
Vimian Group AB
Vimian Group AB Vimian Group AB Valor: 111662981
starstarstarstarstar

Annual Return

-50%0%+50%

Risk level

110
0.34%SEK 29.34
Eurofins Scientific SE
Eurofins Scientific SE Eurofins Scientific SE Valor: 58317129
starstarstarstarstar

Annual Return

-50%0%+50%

Risk level

110
-1.51%EUR 62.52
Patterson Companies Inc
Patterson Companies Inc Patterson Companies Inc Valor: 1896660
starstarstarstarstar

Annual Return

-50%0%+50%

Risk level

110
0.00%USD 31.33
Arrowhead Pharmaceuticals Inc
Arrowhead Pharmaceuticals Inc Arrowhead Pharmaceuticals Inc Valor: 32193461
starstarstarstarstar

Annual Return

-50%0%+50%

Risk level

110
-5.54%USD 36.81
BridgeBio Pharma Inc
BridgeBio Pharma Inc BridgeBio Pharma Inc Valor: 48204826
starstarstarstarstar

Annual Return

-50%0%+50%

Risk level

110
-0.20%USD 54.92
Centene Corp
Centene Corp Centene Corp Valor: 1313733
starstarstarstarstar

Annual Return

-50%0%+50%

Risk level

110
-1.04%USD 35.27
Concentra Group Holdings Parent Inc
Concentra Group Holdings Parent Inc Concentra Group Holdings Parent Inc Valor: 136105334
starstarstarstarstar

Annual Return

-50%0%+50%

Risk level

110
0.10%USD 19.92
dentalcorp Holdings Ltd
dentalcorp Holdings Ltd dentalcorp Holdings Ltd Valor: 111405816
starstarstarstarstar

Annual Return

-50%0%+50%

Risk level

110
0.00%CAD 10.89
Edgewise Therapeutics Inc
Edgewise Therapeutics Inc Edgewise Therapeutics Inc Valor: 110444153
starstarstarstarstar

Annual Return

-50%0%+50%

Risk level

110
-1.70%USD 15.06